Literature DB >> 11457452

Furin and membrane type-1 metalloproteinase mRNA levels and activation of metalloproteinase-2 are associated with arterial remodeling.

D P de Kleijn1, J P Sluijter, J Smit, E Velema, W Richard, A H Schoneveld, G Pasterkamp, C Borst.   

Abstract

Matrix metalloproteinase (MMP) activation is an essential feature of pathological and physiological arterial enlargement or shrinkage. Recently, furin-activated membrane type-1 MMP (MT1-MMP) was identified as the in vivo activator of MMP2 in mice. Although arterial enlargement and shrinkage are important in several pathological processes, this proprotein convertase-MT1-MMP axis has not been described during arterial remodeling. In rabbit femoral and carotid arteries, we report an increase in furin and MT1-MMP mRNA levels before and at the onset of arterial remodeling followed by an increase in activated MMP2. This reveals the presence of the proprotein convertase-MT1-MMP axis in flow-induced arterial remodeling and identifies furin as a possible target for local intervention in pathological arterial remodeling.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11457452     DOI: 10.1016/s0014-5793(01)02622-9

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  9 in total

1.  Chronic hyperhomocysteinemia causes vascular remodelling by instigating vein phenotype in artery.

Authors:  Poulami Basu; Natia Qipshidze; Utpal Sen; Srikanth Givvimani; Charu Munjal; Paras K Mishra; Suresh C Tyagi
Journal:  Arch Physiol Biochem       Date:  2011-08-13       Impact factor: 4.076

2.  Morphologic Features of Carotid Plaque Rupture Assessed by Optical Coherence Tomography.

Authors:  S Shindo; K Fujii; M Shirakawa; K Uchida; Y Enomoto; T Iwama; M Kawasaki; Y Ando; S Yoshimura
Journal:  AJNR Am J Neuroradiol       Date:  2015-08-13       Impact factor: 3.825

Review 3.  Proprotein convertases furin and PC5: targeting atherosclerosis and restenosis at multiple levels.

Authors:  Philipp Stawowy; Eckart Fleck
Journal:  J Mol Med (Berl)       Date:  2005-10-22       Impact factor: 4.599

4.  Fluid shear stress promotes proprotein convertase-dependent activation of MT1-MMP.

Authors:  Hojin Kang; Camille L Duran; Colette A Abbey; Roland R Kaunas; Kayla J Bayless
Journal:  Biochem Biophys Res Commun       Date:  2015-03-20       Impact factor: 3.575

5.  Rare, nonsynonymous variant in the smooth muscle-specific isoform of myosin heavy chain, MYH11, R247C, alters force generation in the aorta and phenotype of smooth muscle cells.

Authors:  Shao-Qing Kuang; Callie S Kwartler; Katerina L Byanova; John Pham; Limin Gong; Siddharth K Prakash; Jian Huang; Kristine E Kamm; James T Stull; H Lee Sweeney; Dianna M Milewicz
Journal:  Circ Res       Date:  2012-04-17       Impact factor: 17.367

6.  The acute phase protein haptoglobin is locally expressed in arthritic and oncological tissues.

Authors:  Mirjam B Smeets; Jolanda Fontijn; Annemieke Kavelaars; Gerard Pasterkamp; Dominique P V De Kleijn
Journal:  Int J Exp Pathol       Date:  2003-04       Impact factor: 1.925

7.  High-Resolution Intracranial Vessel Wall MRI Findings Among Different Middle Cerebral Artery Territory Infarction Types.

Authors:  So Yeon Won; Jihoon Cha; Hyun Seok Choi; Young Dae Kim; Hyo Suk Nam; Ji Hoe Heo; Seung-Koo Lee
Journal:  Korean J Radiol       Date:  2022-03       Impact factor: 3.500

8.  Bone marrow alterations and lower endothelial progenitor cell numbers in critical limb ischemia patients.

Authors:  Martin Teraa; Ralf W Sprengers; Peter E Westerweel; Hendrik Gremmels; Marie-José T H Goumans; Tom Teerlink; Frans L Moll; Marianne C Verhaar
Journal:  PLoS One       Date:  2013-01-31       Impact factor: 3.240

9.  Caveolin-1 influences vascular protease activity and is a potential stabilizing factor in human atherosclerotic disease.

Authors:  Juan A Rodriguez-Feo; Willem E Hellings; Frans L Moll; Jean-Paul P M De Vries; Ben J van Middelaar; Ale Algra; Joost Sluijter; Evelyn Velema; Theo van den Broek; William C Sessa; Dominique P V De Kleijn; Gerard Pasterkamp
Journal:  PLoS One       Date:  2008-07-02       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.